Performance and safety of the ZygoFixU zygomatic implant system over the medium and long term
Official title: Prospective, Multicenter, European Clinical Investigation Evaluating the Short and Medium-term Performance and Safety of the Global D ZygoFixU Implant-prosthetic System
Run by Global D · NCT06960460 · Data updated 2026-11-12
This study will test ZygoFixU zygomatic implants to see if they last at least one year and are safe for adults with severe upper-jaw bone loss.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 99 (estimated) |
| Sponsor | Global D Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 3 sites (Toulouse, France and 2 other locations) |
| Status | Recruiting |
| Started | April 10, 2025 |
| Main results expected | September 1, 2030 |
| Study ends | December 31, 2031 |
| Registry record updated | July 2, 2025 |
| Trial ID | NCT06960460 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with completed maxillary growth who are partially or completely edentulous and have advanced maxillary atrophy (Cawood & Howell grades IV–VI) and who require placement of two or four zygomatic implants are ideal candidates.
✕Probably not a fit
Patients with adequate maxillary bone for standard implants, general contraindications to implant surgery, or serious medical comorbidities are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The ZygoFixU range includes zygomatic implants, prosthetic components, and placement instruments that are similar in design to existing zygomatic systems but are not CE-marked. This is an open-label, non-comparative, prospective multicentre clinical investigation (class IIb) conducted at sites in France and Italy to document device performance and safety. Experienced oral and cranio-maxillofacial surgeons will place two or four implants per patient and patients will be followed with a primary endpoint of implant survival at one year postoperatively. The trial aims to demonstrate conformity with regulatory requirements under the MDR by collecting medium-term performance and safety data.
Why it matters
Potential benefit: If successful, the ZygoFixU system could provide a reliable option to restore function with fixed prostheses for patients who have severe maxillary bone loss.
How similar studies have gone: Zygomatic implants have an extensive published track record with generally high short- and medium-term survival rates, although this specific ZygoFixU device is unapproved and is being tested for conformity and safety.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult male or female patient, * Patient whose growth and development of the maxillary bone is complete according to the investigator's judgement, * Partially or completely edentulous patient, * Patient with advanced maxillary atrophy (grades IV, V and VI according to the Cawood and Howell classification if used), * Patient requiring implant treatment with Global D zygomatic implants (placement of two or four implants), * Patient with acceptable oral opening (\>3 cm measured anteriorly), * Patient able to read, understand and answer the quality-of-life questionnaire of the investigation and able to give consent, * Patient agreeing to comply with the protocol design and to send his/her follow-up data, even in the event of a move, * Patient having signed the consent form, * In France, patient affiliated to a social security scheme. Exclusion Criteria: * Patient's state of health at enrolment: * General contraindications to implant surgery * Patient with zygomatic bone disease * Patient with untreated periodontal disease * Patient with acute or chronic infection in the implant placement area, or systemic infection, including acute or chronic maxillary sinusitis * Patient with acute or chronic inflammation in the implant placement area, or systemic inflammation, * Patient with uncontrolled diabetes (unstable blood glucose) * Patient with immunodeficiencies or using immunosuppressants * Patient who received radiation of more than +70 Gy to the head and neck region * Patient using intravenous aminobisphosphonates within 5 years prior to surgery * Patient who are smokers (\>10 cigarettes/day) or with alcohol or drug addiction * Person placed under legal protection (this includes guardianship, curatorship and legal protection). * Pregnant or breastfeeding women
Where it's running
-
Cabinet dentaire Dr HADJ
Marseille, France Recruiting -
CCOI Toulouse
Toulouse, France, France Not yet recruiting -
Université de Bologne
Bologne, Italie, Italy Not yet recruiting
Study contacts
- Study coordinator: Karen LOUIS
- Email: clinical@globald.com
- Phone: 0615293325
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Graftless Periosteal Coverage vs Xenogenic Graft for Jumping Gap in Immediate Mandibular Molar Implants
This study tests whether graftless periosteal coverage can perform as well as a xenogenic bone graft beneath a collagen membrane for managing a jumping gap in immediate mandibular molar implants.
-
Accuracy of the Calibrated Framework for Full-Arch Implant Impressions in Edentulous Patients
This study tests whether digital scanning with a calibrated framework can match the accuracy of traditional splinted impressions for full-arch dental implants in completely toothless patients.
-
Passive Fit of Implant-Supported Frameworks Using Digital vs Conventional Impressions
This study tests whether three impression methods can produce a passively fitting full-arch mandibular implant framework for edentulous patients.
-
Comparing two bone grafts to preserve the socket after tooth extraction
This test will compare an allograft and a bovine xenograft to see which better preserves jaw bone and gum shape after tooth extraction in healthy adults aged 21–50.
-
Movement of Dental Implants During Osseointegration
This multicenter observational study tests whether dental implants shift in position during the healing period before loading in adults needing a single implant-supported tooth.
-
Natural bioactive gel to treat peri-implantitis around dental implants.
This study will try adding a natural bioactive gel (Sterify Gel®) to standard non-surgical cleaning to see if adults with peri-implantitis have less inflammation and bone loss around their implants.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.